Korro Bio (KRRO) Exchange Rate Effect (2024 - 2026)

Korro Bio's (KRRO) quarterly Exchange Rate Effect came in at -$25000.0 in Q1 2026, down 133.33% on a QoQ basis from $75000.0 in Q4 2025.

Korro Bio (KRRO) Exchange Rate Effect (2024 - 2026) Analysis & Trends

Korro Bio (KRRO) has 3 years of Exchange Rate Effect data on file, last reported at -$25000.0 in Q1 2026.

Quarterly Exchange Rate Effect changed N/A year-over-year to -$25000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39000.0 (up 1075.0% YoY) and the FY2025 annual result came in at $64000.0, up 1700.0% from the prior year.
Exchange Rate Effect declined to -$25000.0 in Q1 2026, from $75000.0 in the prior quarter.
In the past five years, Exchange Rate Effect ranged from a high of $75000.0 in Q4 2025 to a low of -$25000.0 in Q1 2026.
A 3-year average of $7000.0 and a median of -$4000.0 in 2024 frame the typical range for Exchange Rate Effect.
The widest YoY moves for Exchange Rate Effect: up 1975.0% in 2025, down 1975.0% in 2025.
Tracing KRRO's Exchange Rate Effect over 3 years: stood at -$4000.0 in 2024, then surged by 1975.0% to $75000.0 in 2025, then sank by 133.33% to -$25000.0 in 2026.
The last three Exchange Rate Effect figures came in at -$25000.0 (Q1 2026), $75000.0 (Q4 2025), and -$2000.0 (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Vertex Pharmaceuticals	139.05 Bn	131.20 Bn	2.84 Bn	-3.70 Mn
2	Regeneron Pharmaceuticals	85.99 Bn	78.00 Bn	3.93 Bn	-300,000.00
3	Argenx Se	65.49 Bn	60.31 Bn	1.37 Bn	-
4	Moderna	56.79 Bn	51.65 Bn	52.00 Mn	-2.00 Mn
5	BeOne Medicines	42.14 Bn	37.05 Bn	1.53 Bn	19.84 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.27 Bn	992.69 Mn	-2.45 Mn
7	BioNTech SE	27.71 Bn	9.32 Bn	668.28 Mn	1.63 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-287,000.00
9	Royalty Pharma	27.35 Bn	26.51 Bn	-	-
10	Korro Bio	234.33 Mn	119.29 Mn	-	22,000.00

Download Data